Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

Corominas-Faja, Bruna

Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer. [electronic resource] - Histology and histopathology Jul 2017 - 687-698 p. digital

Publication Type: Journal Article

1699-5848

10.14670/HH-11-830 doi


4-Butyrolactone--analogs & derivatives
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Breast Neoplasms--drug therapy
Cell Cycle--drug effects
Cell Line, Tumor
Enzyme Inhibitors--pharmacology
Fatty Acid Synthase, Type I--antagonists & inhibitors
Female
Gene Expression Regulation, Neoplastic--drug effects
Humans
MCF-7 Cells
Oncogenes--genetics
Prognosis
Receptor, ErbB-2--drug effects
Survival Analysis